id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2019-D-4212-0001,FDA,FDA-2019-D-4212,"Wholesale Distributor Verification Requirement for Saleable Returned
Drug Product—Compliance Policy; Guidance for Industry; Availability",Notice,Notice of Availability,2019-09-24T04:00:00Z,2019,9,2019-09-24T04:00:00Z,,2019-09-24T16:25:13Z,2019-20651,0,0,0900006483fbd372
FDA-2019-D-4212-0003,FDA,FDA-2019-D-4212,"Wholesale Distributor Verification Requirement for Saleable Returned
Drug Product—Compliance Policy; Guidance for Industry; Availability",Notice,Notice of Data Availability,2019-09-24T04:00:00Z,2019,9,2019-09-24T04:00:00Z,,2019-09-25T17:42:38Z,2019-20651,0,0,0900006483fbc63c
FDA-2019-D-4212-0002,FDA,FDA-2019-D-4212,Final Guidance for Industry on Wholesale Distributor Verification Requirement for Saleable Returned Drug Product - Compliance Policy,Other,Guidance,2019-09-24T04:00:00Z,2019,9,2019-09-24T04:00:00Z,,2023-09-01T13:55:29Z,,0,0,0900006483fbd762